Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of varenicline in the first trimester on major birth defects in liveborn children

Trial Profile

Study of varenicline in the first trimester on major birth defects in liveborn children

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2018

At a glance

  • Drugs Varenicline (Primary)
  • Indications Smoking withdrawal
  • Focus Adverse reactions
  • Acronyms MUMS
  • Most Recent Events

    • 21 Sep 2018 New trial record
    • 26 Aug 2018 Results evaluating whether varenicline was more effective than NRT presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
    • 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top